美國X 光成像市場規模、佔有率和趨勢分析報告：按應用、規模和細分市場預測，2025 年至 2033 年

美國X光成像市場趨勢：

預計到 2024 年，美國X 光成像市場規模將達到 3.6598 億美元，2025 年至 2033 年的複合年成長率為 11.95%。

監管措施、醫療保健進步和國家安全優先事項推動著成長。由美國能源局主導的銫輻照器更換計劃(CIRP) 為醫院、實驗室和血液中心提供資金和支持，以非放射性 X光系統取代基於銫-137 的設備。癌症、移植手術和免疫力缺乏患者的增加推動了對安全高效的血液輻照技術的需求。此外，美國擁有世界上最大的生物醫學研究網路之一，在聯邦研究津貼和機構投資的支持下，X光輻照器擴大用於放射生物學、腫瘤學和臨床前應用。 FDA 和 NRC 等機構的嚴格法律規範使美國在採用創新、安全且合規的 X光輻照解決方案方面始終處於領先地位。

醫療設備產業的發展也因企業擴張而進一步得到支持，這反映了市場對非放射性、擴充性滅菌解決方案日益成長的需求，例如 Sterigenics 公司於 2025 年 5 月宣布將在美國東南部開設新的 X光滅菌設施。此舉凸顯了區域內對安全高效的醫療設備滅菌服務日益成長的需求，尤其是在監管審查日益嚴格、醫療保健提供者和製造商尋求伽馬射線和環氧乙烷滅菌方法的替代方案的情況下。此類投資有助於縮短週轉時間並降低物流成本，與國家現代化滅菌基礎設施和逐步淘汰放射性物質的努力一致，並支持美國在先進 X光輻照技術領域的市場領先地位。

隨著醫療設備製造商、製藥公司和醫療保健提供者尋求更具成本效益和合規性的解決方案，向外包滅菌服務的轉變正在推動該行業的顯著成長。透過與專門從事滅菌的第三方提供者合作，這些組織可以減少內部基礎設施的資本投資，並受益於成熟服務供應商的專業知識、擴充性和監管能力。例如，IBA 與 Steri-Tek 達成協議，將於 2024 年 6 月部署完全整合的 Be Wide X光解決方案，這清楚地表明了服務供應商如何擴展其能力以滿足不斷成長的客戶需求。諸如此類的發展顯示外包趨勢如何推動市場投資和創新。

美國癌症發生率的上升推動了對安全可靠的輸血實踐和先進研究工具的需求，這些都是 X 光輻照市場的主要驅動力。接受化療、放射線治療和骨髓移植的癌症患者的免疫力缺乏嚴重受損，需要輻照血液成分來預防輸血相關移植物抗宿主疾病 (TA-GvHD) 等危及生命的疾病。這導致醫院和輸血中心採用 X 光血液輻照系統作為銫基系統的安全替代品。此外，美國學術機構和生物製藥公司腫瘤學研究的快速成長推動了對用於放射生物學和癌症建模的精密桌上型X光設備的需求。根據美國癌症協會的數據，預計到 2024 年將新增 200 多萬例癌症病例，對安全輸血通訊協定和專門癌症研究基礎設施的需求將繼續支持強勁的市場成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第 3 章美國X光曝光市場變數、趨勢與範圍

• 市場體系展望
  • 補貼市場展望
• 市場動態
  • 市場促進因素分析
  • 市場限制因素分析
  • 市場機會分析
  • 市場問題分析
• 美國X光輻射市場分析工具
  • 產業分析-波特五力分析
  • PESTEL分析

第4章：美國X光成像市場：應用評估與趨勢分析

• 細分儀表板
• 美國X光成像市場：應用變化分析和市場佔有率（2024年和2033年）
• 醫療設備
• 製藥
• 生物技術和實驗室用品
• 其他

第5章：美國X光成像市場：規模估計與趨勢分析

• 細分儀表板
• 美國X光成像市場：2024年和2033年規模變化分析和市場佔有率
• 小規模
• 中等尺寸
• 大規模

第6章 競爭態勢

• 主要市場參與企業的近期趨勢和影響分析
• 公司/競爭對手分類
  • 創新者
• 供應商格局
  • 主要經銷商和通路合作夥伴名單
  • Key customers
  • Key company market share analysis, 2024
  • STERIS
  • SteriTek, Inc.
  • Sterigenics US, LLC
  • IBA Industrial Solutions
  • E-BEAM Services, Inc
  • KUB Technologies Inc.
  • Precision X-Ray
  • Hopewell Designs, Inc
  • Raycision Medical Technology Co.
  • PTW Freiburg GmbH

U.S. X-ray Irradiation Market Trends:

The U.S. X-ray irradiation market size was valued at USD 365.98 million in 2024 and is expected to grow at a CAGR of 11.95% from 2025 to 2033. The growth is attributed to a combination of regulatory initiatives, healthcare advancements, and national security priorities. A key driver is the Cesium Irradiator Replacement Project (CIRP) led by the U.S. Department of Energy, which provides funding and support for replacing cesium-137-based devices with non-radioactive X-ray systems in hospitals, research labs, and blood centers. The growing prevalence of cancer, transplant procedures, and immunocompromised patient populations has heightened the need for safe, efficient blood irradiation technologies. Moreover, the U.S. hosts one of the world's largest biomedical research networks, where X-ray irradiators are increasingly used for radiobiology, oncology, and preclinical applications, strengthened by federal research grants and institutional investments. With strict regulatory oversight from agencies like the FDA and NRC, the U.S. remains at the forefront of adopting innovative, secure, and compliant X-ray irradiation solutions.

The industry is further propelled by expansions, such as in May 2025, Sterigenics' announcement of new X-ray sterilization capabilities in the Southeast United States, reflecting rising demand for non-radioactive, scalable sterilization solutions. This move underscores the growing need for regional access to safe and efficient medical device sterilization, particularly as healthcare providers and manufacturers seek alternatives to gamma and ethylene oxide methods amid increasing regulatory scrutiny. Such investments support faster turnaround times and reduced logistics costs and align with national efforts to modernize sterilization infrastructure and phase out radioactive materials, supporting the U.S. market's leadership in advanced X-ray irradiation technologies.

The growing shift toward outsourcing sterilization services significantly drives the industry, as medical device manufacturers, pharmaceutical firms, and healthcare providers seek more cost-effective and compliant solutions. By partnering with specialized third-party sterilization providers, these organizations can reduce capital investments in in-house infrastructure and benefit from established service providers' expertise, scalability, and regulatory readiness. For instance, IBA's agreement with Steri-Tek in June 2024 to install a fully integrated Be Wide X-ray solution underscores how service providers are expanding capacity to meet growing client needs. These developments illustrate how outsourcing trends fuel investment and innovation in the market.

The rising prevalence of cancer in the U.S. is a major driver of the X-ray irradiation market, as it increases the demand for safe and reliable blood transfusion practices and advanced research tools. Cancer patients undergoing chemotherapy, radiation therapy, or bone marrow transplants are highly immunocompromised and require irradiated blood components to prevent life-threatening conditions such as Transfusion-associated Graft versus Host Disease (TA-GvHD). This has led to the adoption of X-ray blood irradiators in hospitals and transfusion centers as a safer alternative to cesium-based devices. Additionally, the surge in oncology research across U.S. academic institutions and biopharma companies fuels demand for precise, benchtop X-ray systems used in radiobiology and cancer modeling. According to the American Cancer Society, with over 2 million new cancer cases projected in 2024, the need for safe transfusion protocols and cancer-focused research infrastructure continues to support strong growth in the market.

U.S. X-ray Irradiation Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. X-ray irradiation market report on the basis of application and size:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Medical Devices
  • Pharmaceuticals
  • Biotech & Laboratory Supplies
  • Others
• Size Outlook (Revenue, USD Million, 2021 - 2033)
  • Small-scale
  • Mid-scale
  • Large-scale

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Purchased database.
• 1.5. GVR's internal database
• 1.6. Secondary sources
• 1.7. Third Party Perspective
• 1.8. Primary research
• 1.9. Details of primary research
• 1.10. Information or Data Analysis
• 1.11. Data analysis models
• 1.12. Market Formulation & Validation
• 1.13. Model Details
• 1.14. Commodity flow analysis (Model 1)
  • 1.14.1. Approach 1: Commodity flow approach
• 1.15. Volume price analysis (Model 2)
  • 1.15.1. Approach 2: Volume price analysis
• 1.16. List of Secondary Sources
• 1.17. List of Primary Sources
• 1.18. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. X-ray Irradiation Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Shift away from radioisotopes
    • 3.2.1.2. Rising healthcare demands
    • 3.2.1.3. Technological advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High initial investment
    • 3.2.2.2. Limited awareness in developing regions
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Growing biotech and research applications
  • 3.2.4. Market Challenges Analysis
    • 3.2.4.1. Competition from E-beam and gamma irradiation
• 3.3. U.S. X-ray Irradiation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. X-ray Irradiation Market: Application Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. X-ray Irradiation Market: Application Movement Analysis & Market Share, 2024 & 2033
• 4.3. Medical Devices
  • 4.3.1. Medical Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Pharmaceuticals
  • 4.4.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Biotech & Laboratory Supplies
  • 4.5.1. Biotech & Laboratory Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Others
  • 4.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. X-ray Irradiation Market: Size Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. X-ray Irradiation Market: Size Movement Analysis & Market Share, 2024 & 2033
• 5.3. Small-scale
  • 5.3.1. Small-scale Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. Mid-scale
  • 5.4.1. Mid-scale Market Estimates and Forecasts 2021 to 2033 (USD Million)
• 5.5. Large-scale
  • 5.5.1. Large-scale Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
  • 6.2.1. Innovators
• 6.3. Vendor Landscape
  • 6.3.1. List of key distributors and channel partners
  • 6.3.2. Key customers
  • 6.3.3. Key company market share analysis, 2024
  • 6.3.4. STERIS
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. SteriTek, Inc.
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Sterigenics U.S., LLC
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. IBA Industrial Solutions
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. E-BEAM Services, Inc
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. KUB Technologies Inc.
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Precision X-Ray
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Hopewell Designs, Inc
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. Raycision Medical Technology Co.
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives
  • 6.3.13. PTW Freiburg GmbH
    • 6.3.13.1. Company overview
    • 6.3.13.2. Financial performance
    • 6.3.13.3. Product benchmarking
    • 6.3.13.4. Strategic initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 U.S. X-ray irradiation market, by application, 2021 - 2033 (USD Million)
• Table 4 U.S. X-ray irradiation market, by size, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Automated medical washer disinfector market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2024)
• Fig. 10 Segment outlook
• Fig. 11 Strategy framework
• Fig. 12 Penetration & growth prospect mapping
• Fig. 13 Consumer behavior analysis
• Fig. 14 Market driver relevance analysis (Current & future impact)
• Fig. 15 Market restraint relevance analysis (Current & future impact)
• Fig. 16 Porter's Five Forces analysis
• Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
• Fig. 18 Medical devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 19 Pharmaceuticals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 20 Biotech & laboratory supplies mastectomy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 21 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 22 Small-scale market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 23 Mid-scale market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 24 Large-scale market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• Fig. 25 Company market share analysis, 2024
• Fig. 26 Market differentiators